Keyphrases
Neisseria Meningitidis Serogroup B
100%
Cost-of-illness Analysis
100%
Invasive Pneumococcal Disease
100%
MenB
83%
Netherlands
66%
Human Capital
50%
Long-term Sequelae
50%
Amsterdam
33%
Economic Burden
33%
Indirect Costs
33%
Direct Costs
33%
Case Fatality Rate
33%
Am(III)
16%
Productivity Loss
16%
Societal Costs
16%
Societal Perspective
16%
Rare Diseases
16%
Disease Incidence
16%
Direct Medical Costs
16%
Laboratory-based
16%
Reference Laboratory
16%
Friction Cost Approach
16%
Plain Language Summary
16%
Treatment Costs
16%
Public Health Response
16%
Acute Phase
16%
Sepsis
16%
Serogroup B
16%
Neisseria Meningitidis
16%
Bacterial Meningitis
16%
Meningitis
16%
Indirect Medical Costs
16%
Estimated Cost
16%
Human Capital Costs
16%
Medicine and Dentistry
Health Care Cost
100%
Neisseria meningitidis
100%
Cost of Illness
100%
Meningococcal Disease
100%
Sequela
66%
Public Health
8%
Morbidity
8%
Mortality Rate
8%
Rare Disease
8%
Serotype
8%
Case Fatality Rate
8%
Meningitis
8%
Bacterial Meningitis
8%
Sepsis
8%
Adolescence
8%
Immunology and Microbiology
Neisseria meningitidis
100%
Meningitis
100%
Serotype
50%
Mortality Rate
50%
Case Fatality Rate
50%
Morbidity
50%
Adolescence
50%
Agricultural and Biological Sciences
Neisseria meningitidis
100%
Annuals
50%
Morbidity
50%
Serotype
50%
Nutrition Policy
50%
Adolescence
50%
Earth and Planetary Sciences
Netherlands
100%
Human Capital
100%
Adolescent
25%
Nutrition Policy
25%